Procedural Management of Atrial Fibrillation in Older Patients
Open Access
- 20 August 2026
- journal article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (8)
Abstract
Atrial fibrillation (AF) is becoming increasingly prevalent worldwide because of population aging and the widespread availability of continuous rhythm monitoring. While medical therapy remains central to management, several procedural strategies are being considered for older patients, including catheter ablation with pulsed field ablation (PFA), atrioventricular node ablation with conduction system pacing (CSP), leadless pacemaker (LPM) implantation, and percutaneous left atrial appendage occlusion (LAAO). Catheter ablation is an established therapy that reduces AF burden and improves quality of life; however, the role of catheter ablation in older patients has historically been limited by higher complication rates and greater arrhythmia recurrence. The emergence of PFA may expand the role of ablation because of its procedural efficiency and favorable safety profile, although randomized data in older patients remain limited. A pace-and-ablate strategy with CSP offers an alternative for older patients with symptomatic persistent AF or tachy-brady syndrome. Indeed, by engaging the native conduction system, CSP provides more physiological ventricular activation and may reduce the risk of pacing-induced cardiomyopathy. LPMs avoid the lead- and pocket-related complications associated with transvenous pacemakers and may be especially advantageous in frail older patients with multiple comorbidities. LAAO is a potential strategy for stroke prevention that is often proposed for patients unable to tolerate long-term anticoagulation, although randomized data remain conflicting. This narrative review evaluates the current evidence supporting these procedures in older patients with AF.Keywords
This publication has 62 references indexed in Scilit:
- Safety and Efficacy of Pulsed Field Ablation for Atrial Fibrillation in Older Patients: An Observational Study at a Large Tertiary Centre in AustraliaJournal of Arrhythmia, 2026
- Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trialAmerican Heart Journal, 2026
- Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial FibrillationJAMA, 2025
- Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial FibrillationJAMA, 2024
- Catheter Ablation for Atrial Fibrillation in Elderly Patients: an Updated Meta-analysis of Comparative StudiesCanadian Journal of Cardiology, 2024
- Pulmonary Vein Isolation or Pace and Ablate in Elderly Patients With Persistent Atrial Fibrillation (ABLATE Versus PACE)—Rationale, Methods, and DesignCanadian Journal of Cardiology, 2024
- Conduction System Pacing and Atrioventricular Node Ablation in Heart Failure: The PACE-FIB Study DesignESC Heart Failure, 2023
- Safety of leadless pacemaker implantation in the very elderlyHeart Rhythm, 2020
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial FibrillationJAMA, 2019
- The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trialAmerican Heart Journal, 2017